Literature DB >> 21975697

Percutaneous endoscopic gastrostomy tube occlusion in malignant peritoneal carcinomatosis-induced bowel obstruction.

Pankaj G Vashi1, Sadie Dahlk, Rohan P Vashi, Digant Gupta.   

Abstract

OBJECTIVE: Percutaneous endoscopic gastrostomy (PEG) tube placement for decompression in advanced peritoneal carcinomatosis with bowel obstruction is a safe and feasible palliative procedure. We describe a rare, previously unreported phenomenon of PEG tube occlusion by gastric mucosal herniation.
METHODS: A consecutive case series of 73 patients with advanced abdominal carcinomatosis-induced bowel obstruction from January 2007 to June 2010. All patients had a 28 Fr (Bard) PEG tube placed for drainage. None of them were surgical candidates due to extensive peritoneal involvement. Patients with PEG tube occlusion as a result of gastric mucosal herniation were further evaluated.
RESULTS: Nineteen patients were men and 54 were women. The mean age was 53.3 years. The most common cancer types were ovary, pancreas, colon, and stomach. All patients had PEG tube functioning well after the procedure with immediate relief of obstructive symptoms. Subsequently, 10 patients developed acute occlusion of PEG tubes with reoccurrence of obstructive symptoms. The time between the placement of the PEG tube and its occlusion ranged from 5 to 129 days. Repeat endoscopy showed the PEG tube occluded with gastric mucosa from the opposite wall. PEG tube was replaced with a 28 Fr balloon replacement tube leading to symptom improvement in all 10 patients.
CONCLUSION: This rare but correctable phenomenon of obliteration of PEG tube from the gastric mucosa should be considered in any patient who develops intermittent occlusive symptoms. This phenomenon can be corrected by replacing the PEG tube with a ballooned replacement tube as well as occasional manipulation of the tube.

Entities:  

Mesh:

Year:  2011        PMID: 21975697     DOI: 10.1097/MEG.0b013e32834b0e2a

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  8 in total

Review 1.  Palliative percutaneous endoscopic gastrostomy placement for gastrointestinal cancer: Roles, goals, and complications.

Authors:  Matthew Mobily; Jitesh A Patel
Journal:  World J Gastrointest Endosc       Date:  2015-04-16

2.  Benefits and risks of a percutaneous endoscopic gastrostomy (PEG) for decompression in patients with malignant gastrointestinal obstruction.

Authors:  Anne Dittrich; Barbara Schubert; Michael Kramer; Felicitas Lenz; Karin Kast; Ulrich Schuler; Markus K Schuler
Journal:  Support Care Cancer       Date:  2017-04-22       Impact factor: 3.603

Review 3.  Malignant Bowel Obstruction Management Over Time: Are We Doing Anything New? A Current Narrative Review.

Authors:  Farhana Shariff; Jessica Bogach; Keegan Guidolin; Ashlie Nadler
Journal:  Ann Surg Oncol       Date:  2021-10-18       Impact factor: 5.344

4.  The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations.

Authors: 
Journal:  Ann Surg Oncol       Date:  2020-04-13       Impact factor: 5.344

5.  Palliative venting percutaneous endoscopic gastrostomy tube is safe and effective in patients with malignant obstruction.

Authors:  Rachel B Issaka; David M Shapiro; Neehar D Parikh; Mary F Mulcahy; Srinadh Komanduri; John A Martin; Rajesh N Keswani
Journal:  Surg Endosc       Date:  2013-12-24       Impact factor: 4.584

6.  Gastroduodenal stents are associated with more durable patency as compared to percutaneous endoscopic gastrojejunostomy in the palliation of malignant gastric outlet obstruction.

Authors:  Daniel S Strand; Ju-En C Thlick; James T Patrie; Monica R Gaidhane; Michel Kahaleh; Andrew Y Wang
Journal:  J Interv Gastroenterol       Date:  2012-10-01

7.  Surgical intervention for malignant bowel obstruction caused by gastrointestinal malignancies.

Authors:  Peng-Ju Chen; Lin Wang; Yi-Fan Peng; Nan Chen; Ai-Wen Wu
Journal:  World J Gastrointest Oncol       Date:  2020-03-15

8.  MASCC multidisciplinary evidence-based recommendations for the management of malignant bowel obstruction in advanced cancer.

Authors:  Ainhoa Madariaga; Jenny Lau; Arunangshu Ghoshal; Tomasz Dzierżanowski; Philip Larkin; Jacek Sobocki; Andrew Dickman; Kate Furness; Rouhi Fazelzad; Gregory B Crawford; Stephanie Lheureux
Journal:  Support Care Cancer       Date:  2022-03-10       Impact factor: 3.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.